These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38069796)

  • 1. Structure, Function and Pharmacology of SLC7 Family Members and Homologues.
    Jeckelmann JM; Zaugg J; Morozova V; Müller J; Kantipudi S; Schroeder M; Graff J; Albrecht C; Altmann KH; Gertsch J; Fotiadis D
    Chimia (Aarau); 2022 Dec; 76(12):1011-1018. PubMed ID: 38069796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Heavy Chain 4F2hc Modulates the Substrate Affinity and Specificity of the Light Chains LAT1 and LAT2.
    Kantipudi S; Jeckelmann JM; Ucurum Z; Bosshart PD; Fotiadis D
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Yeast Cell-Based Transport Assay for the Functional Characterization of Human 4F2hc-LAT1 and -LAT2, and LAT1 and LAT2 Substrates and Inhibitors.
    Kantipudi S; Fotiadis D
    Front Mol Biosci; 2021; 8():676854. PubMed ID: 34124158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Volta Phase Plate Cryo-EM Structure of the Human Heterodimeric Amino Acid Transporter 4F2hc-LAT2.
    Jeckelmann JM; Fotiadis D
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30795505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sub-Nanometer Cryo-EM Density Map of the Human Heterodimeric Amino Acid Transporter 4F2hc-LAT2.
    Jeckelmann JM; Fotiadis D
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32993041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The human LAT1-4F2hc (SLC7A5-SLC3A2) transporter complex: Physiological and pathophysiological implications.
    Kahlhofer J; Teis D
    Basic Clin Pharmacol Toxicol; 2023 Nov; 133(5):459-472. PubMed ID: 36460306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of the human LAT1-4F2hc heteromeric amino acid transporter complex.
    Yan R; Zhao X; Lei J; Zhou Q
    Nature; 2019 Apr; 568(7750):127-130. PubMed ID: 30867591
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Kantipudi S; Harder D; Bonetti S; Fotiadis D; Jeckelmann JM
    Methods Protoc; 2021 Jul; 4(3):. PubMed ID: 34449687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The SLC3 and SLC7 families of amino acid transporters.
    Fotiadis D; Kanai Y; Palacín M
    Mol Aspects Med; 2013; 34(2-3):139-58. PubMed ID: 23506863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Mutations and Ligands on the Thermostability of the l-Arginine/Agmatine Antiporter AdiC and Deduced Insights into Ligand-Binding of Human l-Type Amino Acid Transporters.
    Ilgü H; Jeckelmann JM; Colas C; Ucurum Z; Schlessinger A; Fotiadis D
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29558430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of system L amino acid transporter subtypes in rat placenta and yolk sac.
    Owaydhah WH; Ashton N; Verrey F; Glazier JD
    Placenta; 2021 Jan; 103():188-198. PubMed ID: 33160252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and functional characterisation of System L amino acid transporters in the human term placenta.
    Gaccioli F; Aye IL; Roos S; Lager S; Ramirez VI; Kanai Y; Powell TL; Jansson T
    Reprod Biol Endocrinol; 2015 Jun; 13():57. PubMed ID: 26050671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small molecule inhibitors provide insights into the relevance of LAT1 and LAT2 in materno-foetal amino acid transport.
    Zaugg J; Huang X; Ziegler F; Rubin M; Graff J; Müller J; Moser-Hässig R; Powell T; Gertsch J; Altmann KH; Albrecht C
    J Cell Mol Med; 2020 Nov; 24(21):12681-12693. PubMed ID: 33001560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SLC7 amino acid transporters of the yellow fever mosquito Aedes aegypti and their role in fat body TOR signaling and reproduction.
    Carpenter VK; Drake LL; Aguirre SE; Price DP; Rodriguez SD; Hansen IA
    J Insect Physiol; 2012 Apr; 58(4):513-22. PubMed ID: 22266018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LAT2, a new basolateral 4F2hc/CD98-associated amino acid transporter of kidney and intestine.
    Rossier G; Meier C; Bauch C; Summa V; Sordat B; Verrey F; Kühn LC
    J Biol Chem; 1999 Dec; 274(49):34948-54. PubMed ID: 10574970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of substrates and inhibitors of the human heterodimeric transporter 4F2hc-LAT1 using purified protein and the scintillation proximity radioligand binding assay.
    Kantipudi S; Harder D; Fotiadis D
    Front Physiol; 2023; 14():1148055. PubMed ID: 36895635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heteromeric Amino Acid Transporters in Brain: from Physiology to Pathology.
    Errasti-Murugarren E; Palacín M
    Neurochem Res; 2022 Jan; 47(1):23-36. PubMed ID: 33606172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detergent-induced stabilization and improved 3D map of the human heteromeric amino acid transporter 4F2hc-LAT2.
    Meury M; Costa M; Harder D; Stauffer M; Jeckelmann JM; Brühlmann B; Rosell A; Ilgü H; Kovar K; Palacín M; Fotiadis D
    PLoS One; 2014; 9(10):e109882. PubMed ID: 25299125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Large Neutral Amino Acid Transporter (LAT1) in Cancer.
    Lu X
    Curr Cancer Drug Targets; 2019; 19(11):863-876. PubMed ID: 31376820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recycling of aromatic amino acids via TAT1 allows efflux of neutral amino acids via LAT2-4F2hc exchanger.
    Ramadan T; Camargo SM; Herzog B; Bordin M; Pos KM; Verrey F
    Pflugers Arch; 2007 Jun; 454(3):507-16. PubMed ID: 17273864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.